Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval

作者
David G. Strauss,Yow‐Ming Wang,Jeffry A. Florian,Issam Zineh
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:113 (1): 55-61 被引量:25
标识
DOI:10.1002/cpt.2761
摘要

A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from a US Food and Drug Administration (FDA)-approved reference product. The development and approval of biosimilars is critical to enhancing the availability of safe, effective, and affordable treatment options for patients. Utilization of pharmacodynamic (PD) biomarkers can help streamline biosimilar development programs as the current process can be costly and time-consuming. Whereas PD biomarkers have not been prominently used across biosimilar approvals to date, moving forward, there is ample opportunity to increase the use of PD biomarkers in biosimilar development programs in place of comparative clinical studies with efficacy end point(s). This includes utilizing PD biomarkers that were not used as surrogate end points in approval of reference products. This mini-review summarizes how PD biomarkers have been used in biosimilar development programs to date and then discusses evidentiary considerations for PD biomarkers. In addition, study design considerations for clinical pharmacokinetic and PD assessment of proposed biosimilars are discussed. Finally, the FDA's applied regulatory science activities related to PD biomarkers for biosimilars conducted in support of the FDA's Biosimilars Action Plan are reviewed. This included conducting three clinical studies to address information gaps about PD biomarkers for biosimilars and inform general methodological best practices. In summary, enhancing our understanding of key evidentiary considerations and optimal study designs for incorporating PD biomarkers in the evaluation of proposed biosimilars can help bring more treatment options to patients faster.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
KABLG完成签到,获得积分10
刚刚
Danger完成签到 ,获得积分10
1秒前
吕程校完成签到,获得积分10
1秒前
上官完成签到 ,获得积分10
1秒前
慕青的应助被uTwTu采纳,获得10
2秒前
SDLC完成签到,获得积分10
2秒前
李仔仔完成签到 ,获得积分10
2秒前
锦诗完成签到,获得积分10
3秒前
3秒前
李小鱼完成签到,获得积分10
4秒前
使徒猫完成签到,获得积分10
4秒前
5秒前
郭飒完成签到,获得积分20
6秒前
快乐友灵完成签到,获得积分10
7秒前
lanlan完成签到,获得积分10
7秒前
向阳花完成签到,获得积分10
7秒前
mirror完成签到,获得积分10
8秒前
8秒前
热心市民范女士完成签到 ,获得积分10
8秒前
研友_ZelMmn完成签到,获得积分10
9秒前
木木完成签到,获得积分10
9秒前
呵呵发布了新的文献求助10
9秒前
热情的伊发布了新的文献求助10
9秒前
cx完成签到,获得积分10
9秒前
科研执修完成签到,获得积分10
9秒前
9秒前
白白白完成签到 ,获得积分10
9秒前
Loeop完成签到,获得积分10
9秒前
小小青完成签到,获得积分10
11秒前
12秒前
ppp发布了新的文献求助10
12秒前
13秒前
lydiaabc完成签到,获得积分10
13秒前
ZDU完成签到 ,获得积分10
14秒前
14秒前
CWH发布了新的文献求助10
15秒前
xiaohai1466完成签到 ,获得积分10
16秒前
时尚若雁完成签到,获得积分10
16秒前
安琪完成签到,获得积分10
16秒前
vdhuec完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166570
求助须知:如何正确求助?哪些是违规求助? 9559581
关于积分的说明 21750904
捐赠科研通 7757397
什么是DOI,文献DOI怎么找? 3429170
关于科研通互助平台的介绍 2553530
邀请新用户注册赠送积分活动 2473923